Co-Authors
This is a "connection" page, showing publications co-authored by Alex Spyropoulos and Marc Bonaca.
Connection Strength
0.467
-
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial. Thromb Haemost. 2021 Dec; 121(12):1684-1695.
Score: 0.235
-
Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study. Am Heart J. 2021 05; 235:12-23.
Score: 0.232